1375108-41-0

Basic information

• Product Name: 7-bromo-3-methylquinoline
• Synonyms: 7-bromo-3-methylquinoline
• CAS NO: 1375108-41-0
• Molecular Formula: C10H8BrN
• Molecular Weight: 222.08122
• Mol File: 1375108-41-0.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 7-bromo-3-methylquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 7-bromo-3-methylquinoline(1375108-41-0)
• EPA Substance Registry System: 7-bromo-3-methylquinoline(1375108-41-0)

Safety Data

• Hazardous Substances Data: 1375108-41-0(Hazardous Substances Data)

Upstream product

• 4696-26-8 (E)-1-ethoxyprop-1-ene 
• 59278-65-8 2-amino-4-bromobenzaldehyde 
• 5551-12-2 4-bromo-2-nitrobenzaldehyde 
• 123-38-6 propionaldehyde 
• 928-55-2 ethyl 1-propenyl ether 

Downstream Products

• 1619968-79-4 (S)-3-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-4-(2-fluoro-4-(3-methylquinolin-7-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one 
• 1619968-89-6 (S)-4-(2-fluoro-4-(3-methylquinolin-7-yl)phenyl)-1-methyl-3-((1-propionylpyrrolidinyl)methyl)-1H-1,2,4-triazol-5(4H)-one 

Relevant articles and documents

4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS

The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.

FATTY ACID SYNTHASE INHIBITORS

This invention relates to novel spirocyclic piperidines according to Formula (I) which are inhibitors of fatty acid synthase (FAS), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

FATTY ACID SYNTHASE INHIBITORS

This invention relates to spirocyclic piperidines according to Formula (I) and the use of spirocyclic piperidines for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.